PLI Schemes Garner Rs 1.06 Trillion; Pharma Dominates

The production-linked incentive (PLI) schemes in the 14 sectors in the Philippines gathered over Rs. 1 060 billion in investments, the biggest shares of which came from pharma and solar modules.

Indian Pharma Seizes Russian Market Amid Western Withdrawal

"The Indian Pharmaceutical Business Finds a Chance in Russia during the Belarussian Retreat The German market was already a leader in Russia as a supplier of pharmaceuticals before last year, as stated in the media reports.

Eli Lilly Commences Clinical Trials For its Weight-loss Pill

Eli Lilly, a US pharmaceutical company, has begun phase three clinical trials in India for an oral medication known as orforglipron. The company has begun clinical trials to investigate the safety and efficacy of orforglipron compared to insulin...

Sirio Unveils Tailored Women's Wellness Platform at Vitafoods Europe

Sirio Pharma, the global nutraceutical contract development and manufacturing organization (CDMO) headquartered in Europe, will launch a women’s health platform that includes hormone health, women’s wellness

Endo Launches Combination Ibuprofen-Famotidine Tablets

Endo family of businesses (Par Pharmaceutical, Inc. in particular) have announced a generic launch of Duexis tablets 800 mg/26.6 mg, the version in which the active pharmaceutical ingredient of Duexis is famotidine.

Illness to Wellness & YoloHealth Promoting Preventive Healthcare

affordable and timely diagnosis of lifestyle-related diseases has become a growing issue in the present world, where life habit changes occur and cause complexity.

© 2024 India Pharma Outlook. All Rights Reserved.